Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Nonpeptide substance P antagonists reported by Merck & Co.

March 27, 1998

BTG licenses new anxiolytic to Abiogen

March 27, 1998

Elan's Zonegran granted approvable status by FDA

March 27, 1998

Gene implicated in ALS identified at Johns Hopkins

March 27, 1998

AHP discovers centrally active muscarinic agents

March 27, 1998

Sankyo's kappa-opioid agonist demonstrates potent antinociceptive activity

March 26, 1998

Yamanouchi research yields potential new antipsychotic agents

March 26, 1998

Site of spatial short-term memory at last identified in the human brain

March 26, 1998

MKC-231: a neuroprotective agent with choline uptake and acetylcholine-releasing properties

March 26, 1998

Recent infection: an independent risk factor for acute cerebrovascular ischemia

March 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...